Suministro de medicamento exclusivo Blinatumomab 38,5 microgramos inyectable (Blincyto 38,5 mcg)
TED · 755656-2026Award noticeawardedNo deadline given
Who already wins at this buyer
Firms with recorded awards from Hospital Infantil Universitario Niño Jesús in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ALEXION PHARMA SPAIN, S.L | 2 | €4,418,162 | 2026-07-21 |
| VERTEX PHARMACEUTICALS SPAIN, S.L | 2 | €1,115,324 | 2026-06-04 |
| EUROMED PHARMA SPAIN S.L. | 2 | €849,638 | 2026-08-31 |
| ICU MEDICALPRODUCTOS FARMACEÚTICOS Y HOSPITALARIOS, S.L. | 2 | €279,837 | 2026-08-28 |
| BIOMARIN PHARMACEUTICALS ESPAÑA S.L. | 1 | €77,601,945 | 2026-09-02 |
Full buyer profile: what Hospital Infantil Universitario Niño Jesús buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Suministro de medicamento exclusivo Blinatumomab 38,5 microgramos inyectable (Blincyto 38,5 mcg)
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-05-04 | SUMINISTRO DEL MEDICAMENTO EXCLUSIVO: BLINATUMOMAB (BLINCYTO) | Servicio Madrileno de Salud, Hospital Universitario La Paz ES | 93% |
| 2026-08-31 | Suministro de Medicamento exclusivo Setmelanotida 10mg/ml inyectable 1 ml (IMCIVREE 10MG/ML SOLUCIÓN INYECTABLE) | Hospital Infantil Universitario Niño Jesús ES | 93% |
| 2026-09-02 | Suministro de Medicamentos de distribución exclusiva del laboratorio BIOMARIN PHARMACEUT ESPAÑA S.L. | Hospital Infantil Universitario Niño Jesús ES | 92% |
| 2026-07-21 | Suministro de Medicamentos exclusivos Selumetinib 10 mg cápsula (KOSELUGO 10 mg CAPSULAS DURAS) y Selumetinib 25 mg cápsula (KOSELUGO 25 mg CAPSULAS DURAS) | Hospital Infantil Universitario Niño Jesús ES | 91% |
| 2026-08-12 | Suministro de medicamento exclusivo Ravulizumab | Hospital Infantil Universitario Niño Jesús ES | 91% |
| 2026-07-02 | PNSP HUPA 18/26 | HOSPITAL UNIVERSITARIO PRINCIPE DE ASTURIAS ES | 90% |